Mechanism of free and conjugated neocarzinostatin activity: studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate.
Targeting studies using the anti-cancer agent neocarzinostatin (NCS), conjugated to anti-bodies have shown relatively poor specificity. From the literature, it is unclear whether NCS mediates its effects either in conjugated or unconjugated form. In the present work we have used a conjugate of NCS with transferrin, a biological ligand with a well defined endocytic route, to probe these mechanisms. NCS was covalently coupled to transferrin using the heterobifunctional reagent sulfo-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) and 2-iminothiolane to give a stable thioether-linked conjugate with a ratio of 1.6 mol of NCS per mole of transferrin. The binding activity of transferrin was completely retained. Conjugation of NCS to transferrin resulted in an apparent enhancement of cytotoxicity. However, incubation with excess transferrin had no influence on the observed enhanced toxicity, indicating that endocytosis is not responsible. Further experiments demonstrated that the apparent enhancement was dependent on incubation conditions and not an effect due to endocytosis of ligand. Studies where apo-NCS competed with holo-NCS and transferrin strongly indicated that the cytotoxicity of both NCS and conjugate is mediated by direct entry of the dissociated chromophore into the cell.
Schönlau
F
F
Institute für Strahlenbiologie, Universität Münster, Germany.
Maibücher
A
A
Köhnlein
W
W
Garnett
M C
MC
D001667:Binding, Competitive; D002470:Cell Survival / Q000187:drug effects; D003432:Cross-Linking Reagents; D006801:Humans; D007700:Kinetics; D008301:Maleimides; D012516:Osteosarcoma; D011990:Receptors, Transferrin / Q000032:analysis / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D014407:Tumor Cells, Cultured; D009353:Zinostatin / Q000493:pharmacokinetics / Q000633:toxicity*
D003432:Cross-Linking Reagents; D008301:Maleimides; D011990:Receptors, Transferrin; D014168:Transferrin; C063715:transferrin-neocarzinostatin conjugate; C025285:N-(4-carboxycyclohexylmethyl)maleimide N-hydroxysuccinimide ester; D009353:Zinostatin